Autoimmunity in viral myocarditis

Current Opinion in Rheumatology

Volumn 25, Issue 4, 2013, Pages 502-508

  Reddy, Jay ^a   Massilamany, Chandirasegaran ^a   Buskiewicz, Iwona ^b   Huber, Sally A ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

innate immunity; molecular mimicry; myocarditis

Indexed keywords

EPITOPE; MYOSIN HEAVY CHAIN ALPHA; PATTERN RECOGNITION RECEPTOR; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; AUTOPHAGY; CD4+ T LYMPHOCYTE; DENDRITIC CELL; GENE LOCUS; HAPLOTYPE; HEART; HEART FAILURE; HEART MUSCLE CELL; HOST; HUMAN; INNATE IMMUNITY; MACROPHAGE; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS MYOCARDITIS;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; AUTOPHAGY; HUMANS; IMMUNITY, INNATE; MICE; MOLECULAR MIMICRY; MYOCARDITIS; VIRUS DISEASES;

EID: 84879883252     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283620036     Document Type: Review

References (61)

1. Chacko B, Peter JV, Pichamuthu K, et al. Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care. J Crit Care 2012; 27:106; e101-e106.
2. Ukimura A, Ooi Y, Kanzaki Y, et al. A national survey on myocarditis associated with influenza H1N1pdm 2009 in the pandemic and postpandemic season in Japan. J Infect Chemother 2012. [Epub ahead of print].
3. Corsten MF, Schroen B, Heymans S. Inflammation in viral myocarditis: friend or foe? Trends Mol Med 2012; 18:426-437.
4. Pankuweit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev 2012. [Epub ahead of print].
5. Blauwet LA,Cooper LT.Myocarditis. Prog Cardiovasc Dis 2010; 52:274-288.
6. J.C.S. Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J 2011; 75:734-743.
7. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 2012; 59:779-792.
8. Fairweather D, Petri MA, Coronado MJ, et al. Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol 2012; 8:269-284.
9. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet 2012; 379:738-747.
10. Freeman GL, Colston JT, Zabalgoitia M, et al. Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. Am J Physiol 1998; 274:H249-H258.
11. Badorff C, Lee GH, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5:320-326. (Pubitemid 29124369)
12. Caforio AL, Marcolongo R, Jahns R, et al. Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev 2012. [Epub ahead of print].
13. Portig I, Sandmoeller A, Kreilinger S, et al. HLA-DQB1-polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis. Autoimmunity 2009; 42:33-40.
14. Jin B, Ni H, Geshang Q, et al. HLA-DR4 antigen and idiopathic dilated cardiomyopathy susceptibility: a meta-analysis involving 11,761 subjects. Tissue Antigens 2011; 77:107-111.
15. Caforio AL, Mahon NG, Baig MK, et al. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007; 115:76-83. (Pubitemid 46058614)
16. Dandel M, Wallukat G, Potapov E, et al. Role of beta(1)-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy. Immunobiology 2012; 217:511-520.
17. Fan Y, Weifeng W, Yuluan Y, et al. Treatment with a neutralizing antimurine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation. Virol J 2011; 8:17.
18. Xie Y, Chen R, Zhang X, et al. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart. FEMS Immunol Med Microbiol 2012; 64:343-351.
19. Gui J, Yue Y, Chen R, et al. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-kappaB signaling. PLoS One 2012; 7:e46515.
20. Han B, Jiang H, Liu Z, et al. CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis. Can J Cardiol 2012; 28:239-244.
21. Tarrio ML, Grabie N, Bu DX, et al. PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. J Immunol 2012; 188:4876-4884.
22. Guedes PM, Gutierrez FR, Silva GK, et al. Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease. PLoS Negl Trop Dis 2012; 6:e1630.
23. Liao YH, Xia N, Zhou SF, et al. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol 2012; 59:420-429.
24. Liu Y, Zhu H, Su Z, et al. IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCbeta/Erk1/2/NF- kappaBdependent signaling pathway. Int Immunol 2012; 24:605-612.
25. Martinez NE, Sato F, Kawai E, et al. Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis. Future Virol 2012; 7:593-608.
26. Nindl V, Maier R, Ratering D, et al. Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. Eur J Immunol 2012; 42:2311-2321.
27. Qing K, Weifeng W, Fan Y, et al. Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis. Virol J 2011; 8:267.
28. Xie Y, Chen R, Zhang X, et al. The role of Th17 cells and regulatory T cells in coxsackievirus B3-induced myocarditis. Virology 2011; 421:78-84.
29. Gangaplara A, Massilamany C, Brown DM, et al. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-alpha-reactive CD4 T cells in A/J mice. Clin Immunol 2012; 144:237-249.
30. Massilamany C, Upadhyaya B, Gangaplara A, et al. Detection of autoreactive CD4 T cells using major histocompatibility complex class II dextramers. BMC Immunol 2011; 12:40.
31. Massilamany C, Gangaplara A, Steffen D, et al. Identification of novel mimicry epitopes for cardiac myosin heavy chain-alpha that induce autoimmune myocarditis in A/J mice. Cell Immunol 2011; 271:438-449.
32. Cosper PF, Harvey PA, Leinwand LA. Interferon-gamma causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis. Am J Pathol 2012; 181:2038-2046.
33. Fousteri G, Dave A, Morin B, et al. Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun 2011; 36:210-220.
34. Chen P, Baldeviano GC, Ligons DL, et al. Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4(p) T cells. Clin Exp Immunol 2012; 169:79-88.
35. Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol 2012; 24:401-407.
36. Liu W, Li S, Tian W, et al. Immunoregulatory effects of alpha-GalCer in a murine model of autoimmune myocarditis. Exp Mol Pathol 2011; 91:636-642.
37. Noutsias M, Patil VJ, Maisch B. Cellular immune mechanisms in myocarditis. Herz 2012; 37:830-835.
38. Feng Y, Chao W. Toll-like receptors and myocardial inflammation. Int J Inflam 2011; 2011:170352.
39. Riad A, Westermann D, Zietsch C, et al. TRIF is a critical survival factor in viral cardiomyopathy. J Immunol 2011; 186:2561-2570.
40. Roberts BJ, Moussawi M, Huber SA. Sex differences in TLR2 and TLR4 expression and their effect on coxsackievirus-induced autoimmune myocarditis. Exp Mol Pathol 2012; 94:58-64.
41. Hofmann U, Ertl G, Frantz S. Toll-like receptors as potential therapeutic targets in cardiac dysfunction. Expert Opin Ther Targets 2011; 15:753-765.
42. Mann DL. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 2011; 108:1133-1145.
43. Ramos HJ, Gale M Jr. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr Opin Virol 2011; 1:167-176.
44. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011; 472: 481-485.
45. Vallejo JG. Role of toll-like receptors in cardiovascular diseases. Clin Sci (Lond) 2011; 121:1-10.
46. Abston ED, Coronado MJ, Bucek A, et al. Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol 2012; 2012:129486.
47. Fairweather D, Cooper LT Jr, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol 2013; 38:7-46.
48. Frisancho-Kiss S, Davis SE, Nyland JF, et al. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 2007; 178:6710-6714. (Pubitemid 46847392)
49. Liu W, Huber SA. Cross-talk between cd1d-restricted NKT cells and gammadelta cells in T regulatory cell response. Virol J 2011; 8:32.
50. Huber SA, Roberts B, Moussawi M, et al. Slam haplotype 2 promotes NKT but suppresses vgamma4(p) T-cell activation in coxsackievirus b3 infection leading to increased liver damage but reduced myocarditis. Am J Pathol 2013; 182:401-409.
51. Robinson DP, Huber SA, Moussawi M, et al. Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis. Biol Sex Differ 2011; 2:8.
52. Case LK, Toussaint L, Moussawi M, et al. Chromosome y regulates survival following murine coxsackievirus b3 infection. G3 (Bethesda) 2012; 2:115-121.
53. Cuervo H, Guerrero NA, Carbajosa S, et al. Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol 2011; 187:2656-2665.
54. Rahnefeld A, Ebstein F, Albrecht N, et al. Antigen-presentation capacity of dendritic cells is impaired in ongoing enterovirus myocarditis. Eur J Immunol 2011; 41:2774-2781.
55. Sabino GJ, Hwang SJ, McAllister SC, et al. Interferon-gamma influences the composition of leukocytic infiltrates in murine lyme carditis. Am J Pathol 2011; 179:1917-1928.
56. Oh JE, Lee HK. Autophagy in innate recognition of pathogens and adaptive immunity. Yonsei Med J 2012; 53:241-247.
57. Lee HK, Lund JM, Ramanathan B, et al. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007; 315:1398-1401. (Pubitemid 46399546)
58. Richards AL, Jackson WT. Intracellular vesicle acidification promotes maturation of infectious poliovirus particles. PLoS Pathog 2012; 8:e1003046.
59. Kemball CC, Alirezaei M, Flynn CT, et al. Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo. J Virol 2010; 84:12110-12124.
60. van den Hoorn T, Paul P, Jongsma ML, et al. Routes to manipulate MHC class II antigen presentation. Curr Opin Immunol 2011; 23:88-95.
61. Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007; 26:79-92. (Pubitemid 46109341)